ViaDerma, Inc.
VDRM
Rank in Stocks
#33953
ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United... ViaDerma, Inc., a specialty pharmaceutical enterprise based in the United States, focuses on both the development and commercialization of pharmaceutical products. It also licenses its proprietary technology to other companies within the pharmaceutical sector, addressing various therapeutic areas. The company's primary offering is Vitastem, a topical antibiotic containing tetracycline, effective for treating a broad spectrum of ailments such as cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. Beyond its established products, ViaDerma is dedicated to expanding its pipeline, with ongoing development in fields including advanced topical antibiotics, antifungal treatments for toenails, diabetic amputation recovery, general acne, psoriasis, eczema, burn care, anti-aging and wrinkle-reducing formulations, medical cannabis applications, male pattern baldness, skin cancer, erectile dysfunction, and pain management. Established in 2007, the company operated as Dรฉcor Products International, Inc. until its renaming to ViaDerma, Inc. in May 2014. Its corporate operations are directed from Marina Del Rey, California.
Share Price
$0.0001
Last synced: 2026-11-09
Market Cap
$123.37K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade ViaDerma, Inc. (VDRM)
Category
Healthcare
Operating Margin for ViaDerma, Inc. (VDRM)
Operating Margin as of November 2026 TTM: 30.85%
According to ViaDerma, Inc.'s latest financial reports, its current operating margin (TTM) is 30.85%. At the end of 2023 the company had an operating margin of 30.85%.
Operating Margin history for ViaDerma, Inc. from 2007 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 30.85% | 0.00% |
| 2023 | 30.85% | -31.97% |
| 2022 | 45.35% | -28.96% |
| 2021 | 63.84% | -110.36% |
| 2020 | -616.24% | -81.03% |
| 2019 | -3,249.25% | 110.25% |
| 2018 | -1,545.41% | 16.39% |
| 2017 | -1,327.78% | -2,725.11% |
| 2016 | 50.58% | 3.48% |
| 2015 | 48.88% | 130.02% |
| 2011 | 21.25% | -26.57% |
| 2010 | 28.94% | 14.34% |
| 2009 | 25.31% | -121.09% |
| 2008 | -119.99% | -84.77% |
| 2007 | -787.86% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -99.37% |
DE
|
|
| 19.68% | -99.36% |
DE
|
|
| 13.26% | -99.57% |
JP
|
|
| 17.08% | -99.45% |
CH
|
|
| 14.92% | -99.52% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about ViaDerma, Inc.'s operating margin
What is ViaDerma, Inc.'s operating margin?
ViaDerma, Inc.'s operating margin is 30.85%, as of Nov 2026.
What was ViaDerma, Inc.'s operating margin in 2023?
In 2023, ViaDerma, Inc.'s operating margin was 30.85%, compared with 45.35% in 2022.
How has ViaDerma, Inc.'s operating margin changed since 2018?
From 2018 to 2023, ViaDerma, Inc.'s operating margin was highest in 2021 (63.84%) and lowest in 2019 (-3,249.25%).
How does ViaDerma, Inc.'s operating margin compare with similar companies?
ViaDerma, Inc.'s operating margin (30.85%) is higher than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.